Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dazhu Hongjingtian Capsule for Prevention of Acute Mountain Sickness in Healthy Adults
CTR20240435Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Dazhuhongjingtian in acute mountain sickness (AMS) (2 arms), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd. Started Feb 2024; status: completed.
02
Drugs
Dazhuhongjingtian
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on CTR20240435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240435.